VBIO

Valion Bio, Inc.

2.38 USD

Last updated Sep 12, 01:16 UTC

Yesterday HIGH

$2.38

Yesterday LOW

$2.16

52w HIGH

$80.19

52w LOW

$2.16

EPS

-54.25

PE

-0.04

Next Earnings

Nov 13, 2026

Overview News Government Trades Fundamentals

Valion Bio, Inc. stock is down -57.88% since 30 days ago. The next earnings date is Nov 13, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 4 September’s closed higher than August.

Benzinga Insights

Mon Jul 20, 2026

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million. Advanced Biomed (NASDAQ:ADVB) stock moved
Benzinga Insights

Mon Jul 20, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics (NASDAQ:BRNS) shares
Benzinga Insights

Fri Jul 17, 2026

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million. Advanced Biomed (NASDAQ:ADVB) shares
Benzinga Insights

Thu Jul 16, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-market session. The company's market cap stands at $3.3 million. Stereotaxis (AMEX:STXS) stock increased by 8.51%
Benzinga Newsdesk

Tue Jul 14, 2026

Valion Bio shares are trading lower. The company announced strategic updates for its Entolimod program, including U.S. government engagement, a 200‑fold manufacturing scale‑up, and oncology expansion plans.
Benzinga Insights

Tue Jul 14, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) shares
Benzinga Insights

Thu Jun 25, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-market session. The market value of their outstanding shares is at $77.1 million. Bio-Techne (NASDAQ:TECH) stock moved
Benzinga Newsdesk

Thu Jun 25, 2026

Valion Bio Announces That The Pentagon's Armed Forces Radiobiology Research Institute And National Institute of Allergy and Infectious Diseases Completed Their Design Of Survival Efficacy Protocol To Evaluate The Company's Entolimod To Treat Gastrointestinal Acute Radiation Syndrome

The final AFRRI/NIAID protocol design for Entolimod emanates from the Company's previously announced non-clinical evaluation agreement with NIAID, and closely follows the U.S. House Armed Services Committee's
Benzinga Newsdesk

Thu Jun 18, 2026

Valion Bio Issues $250K Series Securities Under Its April 29, 2025 Securities Purchase Agreement With Undisclosed Investor

https://www.sec.gov/ix?doc=/Archives/edgar/data/1787740/000168316826004956/valion_8k.htm
Benzinga Newsdesk

Thu Jun 11, 2026

Valion Bio shares are trading lower. The company confirmed the FY27 NDAA report directs defense officials to develop a plan for prioritizing radiation and nuclear countermeasures.